ILAMED expands international presence with centres in Kenya, Ethiopia and Thailand
Institute to launch Cairo centre in September 2026 as part of its overseas expansion
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Novartis India launches Pluvicto for PSMA-positive metastatic prostate cancer
Radioligand therapy approved for eligible patients with PSMA-positive prostate cancer in India
Alembic receives USFDA final approval for Tretinoin Cream USP, 0.05%
ANDA approved for Tretinoin Cream USP, 0.05%, referencing Retin-A Cream, 0.05%
Ipca Laboratories and Bhami’s Research Laboratory signs global licensing agreement for subcutaneous…
Agreement enables development and commercialisation of monoclonal antibody products for oncology and inflammatory diseases using…
CDSCO’s cosmetic regulations: The rules exist. The enforcement does not
People have died in India’s aesthetic clinics. Not in rare surgical catastrophes, but in routine cosmetic procedures performed by…
Why ingredient transparency matters more than ever in cosmeceuticals
Dr Aisshwarya Panddit highlights why ingredient transparency has become essential in modern cosmeceuticals amid rising consumer…
Indore Pharma Summit: Mapping the future of India pharma
From AI and smart manufacturing to sustainability,quality culture,faster drug development,and CDMO opportunities,the summit…
Indore Rising: Central India’s next manufacturing powerhouse
Indore Pharma Summit 2026 | 8th May 2026 | Indore Marriott Hotel
Mr Gajanan Patil, COO, H&H Healthcare and Cosmetics
Indore Pharma Summit 2026 | 8th May 2026 | Indore Marriott Hotel
Panel Discussion: From molecule to market faster: Rethinking drug development
Indore Pharma Summit 2026 | 8th May 2026 | Indore Marriott Hotel